Get the Stockscreener App
98.63
2.37%
2.28
After Hours:
98.63
Lemaitre Vascular Inc stock is traded at $98.63, with a volume of 209.09K.
It is up +2.37% in the last 24 hours and up +7.65% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
See More
Previous Close:
$96.35
Open:
$95.97
24h Volume:
209.09K
Relative Volume:
1.87
Market Cap:
$2.22B
Revenue:
$205.62M
Net Income/Loss:
$37.68M
P/E Ratio:
81.51
EPS:
1.21
Net Cash Flow:
$31.69M
1W Performance:
+9.09%
1M Performance:
+7.65%
6M Performance:
+32.89%
1Y Performance:
+103.40%
1-Day Range:
$95.97
$98.81
1-Week Range:
$86.61
$101.67
52-Week Range:
$47.72
$101.67
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
FY2024 EPS Forecast for LeMaitre Vascular Boosted by Analyst - MarketBeat
LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in November - GlobeNewswire
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Earns Outperform Rating from Oppenheimer - MarketBeat
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion - Investing.com
LeMaitre Vascular Inc (LMAT) Trading 12.71% Higher on Nov 1 - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Given New $93.00 Price Target at Barrington Research - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular - Benzinga
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High on Earnings Beat - MarketBeat
LeMaitre Vascular stock target upgraded, keeps buy rating on strong Q3 results - Investing.com UK
Conestoga Capital Advisors LLC Purchases 36,850 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre: Q3 Earnings Snapshot - The Advocate
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings: EPS of $0.49 Beats Estimates, Revenue Hits $54.8 Million - GuruFocus.com
LeMaitre Q3 2024 Financial Results - GlobeNewswire
Congress Asset Management Co. Acquires 18,295 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular Q3 2024 Earnings Preview - MSN
6,169 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Smith Group Asset Management LLC - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.66 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead - MSN
Ausbil Investment Management Ltd Has $1.23 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (LMAT) Set to Announce Earnings on Thursday - MarketBeat
(LMAT) Investment Analysis - Stock Traders Daily
LeMaitre Vascular, Inc. (NASDAQ:LMAT) is Copeland Capital Management LLC's 4th Largest Position - MarketBeat
Insiders At LeMaitre Vascular Sold US$23m In Stock, Alluding To Potential Weakness - Simply Wall St
Cantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral Recommendation - MSN
BAX or LMAT: Which Is the Better Value Stock Right Now? - Yahoo Finance
Vascular Graft Market to Hit $8.1 Billion by 2030 | Cordis, - openPR
YieldBoost LeMaitre Vascular To 13.2% Using Options - Nasdaq
Brokers Issue Forecasts for LeMaitre Vascular, Inc.'s FY2024 Earnings (NASDAQ:LMAT) - MarketBeat
GAMMA Investing LLC Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 - The Manila Times
Cantor Fitzgerald sets price target, neutral rating on LeMaitre Vascular shares - Investing.com Canada
Cardiovascular And Soft Tissue Repair Patches Market Market - openPR
Cantor Fitzgerald Begins Coverage on LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular - Benzinga
The Manufacturers Life Insurance Company Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular And 4 Other Stocks Have Very High Payout Ratio - Via News Agency
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):